Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Topical Minoxidil Appetite & Cravings Changes: What the Evidence Actually Shows

By
Published Updated Last reviewed
6 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Product / minoxidil 5% solution or foam, over the counter
  • Approved use / regrow hair on the top of the scalp [1][2]
  • Appetite on the Drug Facts stop-use list / not listed [1][2]
  • On that list instead / sudden unexplained weight gain, swelling, chest pain, rapid heartbeat, faintness, dizziness, scalp irritation [1][2]

Does topical minoxidil 5% change appetite or cravings?

The topical trials measured hair, not hunger. In a 48-week double-blind trial of 393 men, 5% solution beat 2% solution and placebo on nonvellus hair count, with more itching and local irritation on 5% [3]. A 48-week trial of 381 women found 5% superior to placebo on all three primary measures, with more itching, irritation and hypertrichosis on 5% [4]. Appetite is not among the outcomes described in either trial, so the question is a gap in the data, not evidence that appetite is unaffected.

What the labels list as reasons to stop

The Men's Rogaine Extra Strength 5% solution label (1 mL twice daily, men only, top of the scalp) lists chest pain, rapid heartbeat, faintness or dizziness; sudden, unexplained weight gain; swelling of the hands or feet; scalp irritation or redness; unwanted facial hair growth; and no regrowth after 4 months among its reasons to stop use. It also has a heart-disease caution [1].

The Women's Rogaine 5% foam label (half a capful once daily) lists the same symptoms as reasons to stop use, but specifies no regrowth after 6 months rather than 4 months [2]. Both labels say that using more or more often will not improve results and that continued use is necessary or hair loss will begin again [1][2].

Oral minoxidil is a different product

Minoxidil tablets (Loniten and generics) are a separate prescription product, approved for severe hypertension and not for hair loss [5]. A retrospective study of 1404 patients on low-dose oral minoxidil for hair loss for at least 3 months, with no control group, reported hypertrichosis in 15.1%, lightheadedness in 1.7%, fluid retention in 1.3% and tachycardia in 0.9%, with 1.2% stopping because of systemic effects [6]. Appetite was not among the reported outcomes.

Frequently asked questions

Does topical minoxidil 5% increase appetite?
It is unknown whether topical minoxidil 5% increases appetite. Appetite is not on the Drug Facts stop-use lists, which do include sudden, unexplained weight gain and swelling [1][2].
Can topical minoxidil cause weight gain?
The labels list sudden, unexplained weight gain and swelling of the hands or feet as reasons to stop use [1][2]. In a 1404-patient study of low-dose oral minoxidil, a different product, fluid retention was reported in 1.3% [6].
Is appetite on the labels stop-use list?
No. The list names chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, hand or foot swelling, scalp irritation or redness, unwanted facial hair growth, and no regrowth in 4 months for men or 6 months for women [1][2].
How does oral minoxidil compare?
Oral and topical minoxidil are different products, and the available studies do not establish whether either is more likely to change appetite. A 1404-patient study of low-dose oral minoxidil reported hypertrichosis, lightheadedness and fluid retention, not appetite outcomes [6].

References

  1. U.S. National Library of Medicine, DailyMed. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue prescribing information. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue label
  2. U.S. National Library of Medicine, DailyMed. Women's Rogaine minoxidil 5% topical foam, Kenvue prescribing information. Women's Rogaine minoxidil 5% topical foam, Kenvue label
  3. Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-85. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
  4. Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-53. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
  5. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
  6. Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
Evidence overview for Topical Minoxidil Appetite & Cravings Changes: What the Evidence Actually Shows